資料搜尋諮詢服務
找不到您所需要的資料嗎?
我們能協助您找到最符合您研究需求的資訊
請撥打 +886-2-2799-3110
或透過電子郵件與我們聯絡 mi@hintoninfo.com

頁面路徑選單

出 版 商:
CBR Pharma Insights
(搜尋結果 57 項結果)
排序:
篩選:出版日期: 地區: 搜尋

Pharmaceutical Mergers and Acquisitions - M&A in the Biopharmaceutical Industry and the Impact on Innovation

2009/09/15
Pharmaceutical Mergers and Acquisitions - M&A in the Biopharmaceutical Industry and the Impact on Innovation Summary The history of the pharmaceutic.. more
USD 3,900

Lifecycle Management Strategies - Key tools to maximize return on investment in a tough healthcare environment

2009/09/15
Lifecycle Management Strategies - Key tools to maximize return on investment in a tough healthcare environment Summary Pharmaceutical companies cont.. more
USD 3,900

Biosimilars - The Future Transformation of Product Exclusivity in the Biotechnology Arena

2009/06/15
Biosimilars - The Future Transformation of Product Exclusivity in the Biotechnology Arena Summary The nature of biotechnology has, up until recently.. more
USD 3,900

The Obama Administration and the Pharmaceutical Industry - Overview of the 2009 Recovery Act and the 2010 Federal Budget

2009/06/15
The Obama Administration and the Pharmaceutical Industry - Overview of the 2009 Recovery Act and the 2010 Federal Budget Summary President Obama has.. more
USD 3,900

The New Pharmaceutical Sales Force - Key Trends Shaping Future Sales Strategies

2009/04/15
The New Pharmaceutical Sales Force - Key Trends Shaping Future Sales Strategies Summary There are few companies in the pharmaceutical industry that .. more
USD 3,900

Key Trends Shaping Future Marketing Strategies - Maximizing Your Online Channels

2009/04/15
Key Trends Shaping Future Marketing Strategies - Maximizing Your Online Channels Summary Due to decreasing sales growth, the pharmaceutical industry.. more
USD 3,900

The Pharmaceutical Industry 2009 - The Key R&D Trends Impacting New Product Development

2009/04/15
The Pharmaceutical Industry 2009 - The Key R&D Trends Impacting New Product Development Summary Despite the current economic downturn, pharmaceutica.. more
USD 3,900